Related Experiment Video
Updated: Nov 6, 2025
14:19
Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
28.4K
Fetal Growth and Stillbirth
Jessica M Page1, Nathan R Blue2, Robert M Silver3
1Maternal-Fetal Medicine, Intermountain Healthcare, University of Utah, 5121 South Cottonwood Street, Suite 100, Murray, UT 84107, USA.
Obstetrics and Gynecology Clinics of North America
|May 11, 2021
Summary
Fetal growth restriction (FGR) increases stillbirth risk due to placental issues. Early detection and management, including thorough evaluation of stillbirths, are crucial for risk reduction.
Area of Science:
- Perinatal Medicine
- Reproductive Biology
- Obstetrics
Background:
- Fetal growth restriction (FGR) is a significant indicator of placental insufficiency.
- FGR is recognized as a critical risk factor for stillbirth.
- The association between FGR and stillbirth may be overestimated due to delayed recognition of fetal demise.
Purpose of the Study:
- To highlight the importance of managing maternal conditions and exposures in FGR pregnancies.
- To emphasize the role of antenatal testing and delivery timing in mitigating stillbirth risk.
- To underscore the necessity of comprehensive evaluation for stillbirths in FGR cases.
Main Methods:
- Review of existing literature on FGR and stillbirth.
- Analysis of factors contributing to overestimation of stillbirth risk.
- Discussion of recommended diagnostic and management strategies.
Main Results:
- Optimizing maternal health and implementing appropriate surveillance can reduce stillbirth risk in FGR.
- Comprehensive evaluation of stillbirths is essential for accurate diagnosis and future prevention.
Conclusions:
- Effective management of FGR pregnancies requires a multi-faceted approach.
- Thorough investigation of stillbirths involving fetal autopsy, placental pathology, genetic testing, and serological assessments is critical.
Related Concept Videos
01:07Teratogenicity
3.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.5K
01:14Fetal Circulation
1.8K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.8K
01:10Nature and Nurture
21.3K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
21.3K